Funding rounds backed by Invus.
Develops fungal genome-derived therapeutics for organ transplant rejection
Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas
Develops hormonal and non-hormonal male contraceptives for men and couples globally
Develops and manufactures adaptive robots for complex tasks
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
Develops medicines targeting historically undruggable protein targets in cancer